![The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019) The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)](https://erc.bioscientifica.com/view/journals/erc/26/6/images/ERC-19-0087fig3.jpeg)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
![Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? | Cell and Developmental Biology Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/470308/fcell-07-00154-HTML/image_m/fcell-07-00154-g001.jpg)
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? | Cell and Developmental Biology
![The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019) The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)](https://erc.bioscientifica.com/view/journals/erc/26/6/images/full-ERC-19-0087fig1.jpeg)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
![Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo - ScienceDirect Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332219317512-ga1.jpg)
Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo - ScienceDirect
![Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d5b689a4-87fb-42cd-a3a7-a76751059d93/jnc14687-fig-0007-m.jpg)
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library
![Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients | Scientific Reports Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-50528-y/MediaObjects/41598_2019_50528_Fig1_HTML.png)
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients | Scientific Reports
![Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances | Immunology Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances | Immunology](https://www.frontiersin.org/files/Articles/544407/fimmu-11-01387-HTML/image_m/fimmu-11-01387-g001.jpg)